Intermap Technologies (TSE:IMP) Upgraded at Atrium Research
Atrium Research upgraded shares of Intermap Technologies to a “strong-buy” rating in a report on Thursday.
Source link
Similar Posts
BNY Mellon Income Stock Fund Q2 2024 Commentary
Panya Mingthaisong Describe the performance of the fund relative to its benchmark during the last three months. BNY Mellon Income Stock Fund (Class I shares) underperformed its benchmark, the Dow Jones U.S. Select Dividend Index, during the second quarter of 2024. On a sector basis, financials and materials were the largest contributors, while utilities and…
Why I’m Buying DocuSign Ahead Of Q2 Earnings (NASDAQ:DOCU)
SDI Productions/E+ via Getty Images DocuSign (NASDAQ:DOCU) is down around -8.7% year-to-date and I see this as an opportunity to buy at a fair valuation with a strong cash flow and balance sheet. Second quarter earnings coming soon DocuSign is slated to report its second-quarter earnings on September 5 and this is a good time…
Stock Market News and Research Tools
Ad Stansberry Research Expert issues rare “All In” buy alert on $6 gold stock Is Gold Headed Above $3,000 per Ounce? Here’s How to Play It… With so many strange events happening across the economy (the longest bear market for bonds since the Civil War… unprecedented bank closures… and soaring prices), it’s no wonder the…
OSEL Devices Ltd IPO Latest GMP, Lot Size, and OSEL IPO Updates – Equitypandit
OSEL Devices’ IPO is a book-built issue of Rs 70.66 crores, consisting entirely of a fresh issue of 44.16 lakh shares. The subscription for OSEL Devices’ Initial Public Offering (IPO) commences on September 16, 2024, and concludes on September 18, 2024. The allocation for the OSEL Devices IPO is anticipated to be finalised on Thursday,…
Why Now Is the Perfect Time for IPOs: Insights from Dr. Chiang
In a rapidly evolving economic landscape, timing plays a critical role in business decisions, especially when considering an Initial Public Offering (IPO). Dr. Clemen Chiang, CEO and Founder of Spiking, shares valuable insights in his recent article on Fast Company, delving into why the current moment offers unprecedented opportunities for companies to go public. Dr….
